LAVERN WEBSTER-DOWELL: Open Payments
NPI 1306222419 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,889 in 64 payments from 15 companies in 2025. Trend: 2023 $2,683 · 2024 $1,492 · 2025 $1,889
Food & beverage: $1,625Travel & lodging: $264
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 13 | $432 |
| Neuronetics, Inc. | 2 | $388 |
| Otsuka America Pharmaceutical, Inc. | 5 | $209 |
| ABBVIE INC. | 15 | $162 |
| Axsome Therapeutics, Inc. | 3 | $152 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $119 |
| Alkermes, Inc. | 6 | $107 |
| Teva Pharmaceuticals USA, Inc. | 4 | $76 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $65 |
| Neurocrine BioSciences, Inc. | 2 | $55 |
Products named: FANAPT, NEUROSTAR TMS THERAPY SYSTEM, VRAYLAR, Auvelity, ABILIFY MAINTENA, CAPLYTA, ARISTADA, REXULTI.
Industry payments across FL — which companies pay providers there.
